Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 402Rectal Neoplasms 151Colonic Neoplasms 148Pancreatic Neoplasms 113Stomach Neoplasms 106Neoplasm Metastasis 88Neoplasms 74Esophageal Neoplasms 59Small Cell Lung Carcinoma 44Neuroblastoma 42Lung Neoplasms 42Glioblastoma 38Carcinoma, Non-Small-Cell Lung 37Esophageal Squamous Cell Carcinoma 33Brain Neoplasms 33Unspecified Adult Solid Tumor, Protocol Specific 31Glioma 31Breast Neoplasms 28Central Nervous System Neoplasms 27Adenocarcinoma Of Esophagus 27Sarcoma 26Gliosarcoma 22Astrocytoma 22Rhabdomyosarcoma 21Sarcoma, Ewing 18Adenocarcinoma 18Gastrointestinal Neoplasms 17Oligodendroglioma 16Cholangiocarcinoma 14Recurrence 13

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Alveolar Childhood Rhabdomyosarcoma × Irinotecan × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡